Cite
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
MLA
Ghosh, Nilanjan, et al. “Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.” Biology of Blood & Marrow Transplantation, vol. 23, no. 11, Nov. 2017, pp. 1903–09. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.07.003.
APA
Ghosh, N., Ye, X., Tsai, H.-L., Bolaños-Meade, J., Fuchs, E. J., Luznik, L., Swinnen, L. J., Gladstone, D. E., Ambinder, R. F., Varadhan, R., Shanbhag, S., Brodsky, R. A., Borrello, I. M., Jones, R. J., Matsui, W., & Huff, C. A. (2017). Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma. Biology of Blood & Marrow Transplantation, 23(11), 1903–1909. https://doi.org/10.1016/j.bbmt.2017.07.003
Chicago
Ghosh, Nilanjan, Xiaobu Ye, Hua-Ling Tsai, Javier Bolaños-Meade, Ephraim J. Fuchs, Leo Luznik, Lode J. Swinnen, et al. 2017. “Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.” Biology of Blood & Marrow Transplantation 23 (11): 1903–9. doi:10.1016/j.bbmt.2017.07.003.